Abercrombie & Fitch shares down about 2% premarket after Raymond James cuts to 'Market Perform'
ANF•Related News
Genprex partners with US-based CDMO to scale up manufacturing for diabetes gene therapy program
GNPX•
Evogene Q2 net loss narrows to USD 1.8 million; revenue slips to USD 0.3 million
EVGN•
SoFi Tech Solutions Q2 debit spend index shows experience spending rises 23% from Q1
SOFI•
Eaton names Shawn Black president of aerospace unit
ETN•
US stock futures fall as fading Iran peace prospects drive up oil, yields
SPY•